Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA

被引：0
|
作者：
S Nghiem-Buffet
S Baillif
S Regnier
A Skelly
N Yu
A Sodi
机构：
[1] Centre Ophtalmologique d’Imagerie et de Laser,Department of Ophthalmology
[2] Paris,Department of Ophthalmology
[3] France,Department of Ophthalmology
[4] Hôpital Avicenne,undefined
[5] Assistance Publique,undefined
[6] Hôpitaux de Paris and Paris 13 University,undefined
[7] Pasteur II University Hospital,undefined
[8] Novartis Pharma AG,undefined
[9] Novartis Ireland Limited,undefined
[10] Real-World Evidence Solutions,undefined
[11] IMS Health,undefined
[12] Careggi University Hospital,undefined
来源：
Eye | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：551 / 559
页数：8
相关论文
共 50 条
  • [1] Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA
    Nghiem-Buffet, S.
    Baillif, S.
    Regnier, S.
    Skelly, A.
    Yu, N.
    Sodi, A.
    EYE, 2017, 31 (04) : 551 - 559
  • [2] Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA
    D Călugăru
    M Călugăru
    Eye, 2017, 31 : 1112 - 1113
  • [3] Comments on ‘Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA’
    M A Williams
    C Shute
    S Wright
    Eye, 2018, 32 : 468 - 469
  • [4] Comments on 'Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA'
    Williams, M. A.
    Shute, C.
    Wright, S.
    EYE, 2018, 32 (02) : 468 - 469
  • [5] Sir, Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA
    Calugaru, D.
    Calugaru, M.
    EYE, 2017, 31 (07) : 1112 - 1113
  • [6] Response to Comment on: Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA
    S Nghiem-Buffet
    S Baillif
    S Regnier
    A Skelly
    N Yu
    A Sodi
    Eye, 2017, 31 : 1113 - 1114
  • [7] Sir, Response to Comment on: Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA
    Nghiem-Buffet, S.
    Baillif, S.
    Regnier, S.
    Skelly, A.
    Yu, N.
    Sodi, A.
    EYE, 2017, 31 (07) : 1113 - 1114
  • [8] Efficacy of Dexamethasone Intravitreal Implant Compared with Intravitreal Ranibizumab in Patients with Central Retinal Vein Occlusion and Branch Retinal Vein Occlusion
    Aydin, Erdinc
    Gurakar, Seda
    Egrilmez, Emine Deniz
    OPHTHALMOLOGICA, 2014, 232 : 87 - 87
  • [9] Intravitreal Ranibizumab and/or Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion
    Nghiem-Buffet, Sylvia
    Fajnkuchen, Franck
    Buffet, Marc
    Ayrault, Sandrine
    Le Gloahec-Lorcy, Anna
    Grenet, Typhaine.
    Delahaye-Mazza, Corinne
    Quentel, Gabriel
    Cohen, Salomon Y.
    OPHTHALMOLOGICA, 2014, 232 (04) : 216 - 222
  • [10] Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population
    Gu, Xiaoya
    Yu, Xiaobing
    Song, Shuang
    Dai, Hong
    OPHTHALMIC RESEARCH, 2017, 58 (01) : 8 - 14
12345